Projects per year
Abstract
Cancer cells exhibit heightened secretory states that drive tumor progression. Here, we identified a chromosome 3q amplicon that serves as a platform for secretory regulation in cancer. The 3q amplicon encodes multiple Golgi-resident proteins, including the scaffold Golgi integral membrane protein 4 (GOLIM4) and the ion channel ATPase secretory pathway Ca2+ transporting 1 (ATP2C1). We show that GOLIM4 recruited ATP2C1 and Golgi phosphoprotein 3 (GOLPH3) to coordinate Ca2+-dependent cargo loading, Golgi membrane bending, and vesicle scission. GOLIM4 depletion disrupted the protein complex, resulting in a secretory blockade that inhibited the progression of 3q-amplified malignancies. In addition to its role as a scaffold, GOLIM4 maintained intracellular manganese (Mn) homeostasis by binding excess Mn in the Golgi lumen, which initiated the routing of Mn-bound GOLIM4 to lysosomes for degradation. We show that Mn treatment inhibited the progression of multiple types of 3q-amplified malignancies by degrading GOLIM4, resulting in a secretory blockade that interrupted prosurvival autocrine loops and attenuated prometastatic processes in the tumor microenvironment. As it potentially underlies the selective activity of Mn against 3q-amplified malignancies, ATP2C1 coamplification increased Mn influx into the Golgi lumen, resulting in a more rapid degradation of GOLIM4. These findings show that functional cooperativity between coamplified genes underlies heightened secretion and a targetable secretory addiction in 3q-amplified malignancies.
Original language | English (US) |
---|---|
Article number | e176355 |
Journal | Journal of Clinical Investigation |
Volume | 134 |
Issue number | 12 |
DOIs | |
State | Published - Jun 17 2024 |
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancer'. Together they form a unique fingerprint.Projects
- 1 Active
-
A targeted proteomics and metabolomics mass spectrometry core facility at the University of Texas Medical Branch
Russell, W. (PI)
Cancer Prevention and Research Institute
8/31/19 → 8/31/25
Project: Research project